Genetic Interactions in KRAS-Mutant Cancers: How U2AF1 Mutations Alter Oncogenic Splicing Recent research published in Nature reveals that specific mutations in the splicing factor gene U2AF1 can paradoxically rescue defective …
Tag:
General
-
-
South Carolina Athletics Transitions to Nike Partnership South Carolina Athletics has officially entered a multi-year apparel partnership with Nike, according to an announcement from the University of South Carolina. The …
-
Why Viral Load Doesn’t Predict Symptoms in Influenza A(H3N2) Infections Recent clinical research published in Nature Medicine demonstrates that the severity of influenza A(H3N2) symptoms is not determined by the …
-
Genomic data reanalysis is increasingly identifying the underlying causes of rare diseases by systematically re-examining previously unsolved clinical sequencing results. According to a study published in Nature Medicine, automated workflows …
-
Health
AbbV-706 Antibody-Drug Conjugate Shows Promise in Advanced Small Cell Lung Cancer and Solid Tumors
ABBV-706, an investigational antibody-drug conjugate (ADC) targeting the SEZ6 protein, has shown preliminary clinical activity in patients with advanced small cell lung cancer (SCLC) and other solid tumors, according to …
-
Adaptive Neuromodulation Shows Promise for Improving Parkinsonian Gait Recent research indicates that adaptive neuromodulation can improve gait in patients with Parkinson’s disease by matching stimulation to the right circuit at …
-
The Fragility of the Group of Five: How Realignment is Threatening G5 Stability The instability of the NCAA’s Group of Five (G5) conferences has reached a critical point as member …
-
GM and Lockheed Martin Forge Defense Partnership General Motors has entered talks with Lockheed Martin to produce missile components, a move detailed in a 2023 Reuters report that underscores a …
-
How Histidine Levels Influence Cancer Immunotherapy Response Recent research indicates that dietary histidine levels significantly impact the efficacy of immune checkpoint inhibitor (ICI) therapy in cancer patients. According to a …
-
Finerenone Shows Promise in Treating Chronic Kidney Disease Without Diabetes, Study Finds Finerenone, a non-steroidal mineralocorticoid receptor antagonist, has demonstrated significant benefits in reducing the risk of kidney function decline …